Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM 100

250.00p

Change Today:

-7.00p
52 Week High: 1,194.00
52 Week Low: 249.50

Currency: UK Pounds
Shares Issued: 70.63m
Volume: 190,430

Market Cap: £176.57m
RiskGrade: 453

Trade now with Barclays Stockbrokers

Update - Novacyt S.A. (CDI) is near the bottom of the FTSE AIM 100 - will it stay here? Have a look at Novacyt S.A. (CDI)'s chart Find out more
Update - Novacyt S.A. (CDI) is a top faller in its sector - can you take advantage with spread betting? Find out more

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

6 Month Chart

More Novacyt S.A. (CDI) charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	60.4%	38.2%
ROCE	126.9%

	Latest	F'cast
P/E	1.3	6.4
PEG	n/a	n/a
Pr/Revenue	0.7	1.6
Pr/Book	1.2

	Latest	F'cast
Revenue	2316.7%	-52.3%
PBT	n/a	-69.5%
EPS	n/a	-75.6%
DPS	n/a	n/a

NCYT Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-16	11.08	(5.71)	(47.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-17	12.75	(3.49)	(15.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-18	13.72	(2.08)	(6.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-19	11.47	(3.43)	(8.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	277.20	165.17	194.00p	4.4	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Forecasts

Year Ending	Revenue ( m)	Pre-tax ( m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	111.62	42.59	47.27¢	6.4	n/a	-76%	n/a	0.0%
31-Dec-22	92.20	32.76	36.04¢	8.4	n/a	-24%	n/a	0.0%

Novacyt S.A. (CDI) forecasts

NCYT Company Announcements

Results of annual general meeting	19-Oct-2021	16:15	RNS
Total Voting Rights	01-Oct-2021	14:30	RNS
R&D update	30-Sep-2021	07:00	RNS

More Novacyt S.A. (CDI) ncyt company announcements

NCYT ShareCast News

Novacyt launches new 'Winterplex' test, lateral ...	30-Sep-2021	ShareCast
Novacyt swings to first-half loss amid DHSC disp...	27-Sep-2021	ShareCast
Novacyt FY revenues potentially 'materially affe...	16-Sep-2021	ShareCast

More Novacyt S.A. (CDI) ShareCast news

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

NCYT Market Data

Currency	UK Pounds
Share Price	250.00p
Change Today	-7.00p
% Change	-2.72 %
52 Week High	1,194.00
52 Week Low	249.50
Volume	190,430
Shares Issued	70.63m
Market Cap	£176.57m
RiskGrade	453